Golzari-Sorkheh M, Yoganathan K, Chen E, Singh J, Zuniga-Pflucker J
Adv Exp Med Biol. 2025; 1471:81-137.
PMID: 40067585
DOI: 10.1007/978-3-031-77921-3_4.
Miyazaki K, Horie K, Watanabe H, Hidaka R, Hayashi R, Hayatsu N
Genes Dev. 2025; 39(5-6):384-400.
PMID: 39904558
PMC: 11874989.
DOI: 10.1101/gad.352111.124.
Sakaguchi H, Matsuda M, Iwanami N
Front Immunol. 2025; 15:1517467.
PMID: 39867910
PMC: 11759298.
DOI: 10.3389/fimmu.2024.1517467.
Verma A, Aylward B, Ma F, Sherman C, Chopp L, Shinton S
Sci Adv. 2024; 10(48):eado5982.
PMID: 39602533
PMC: 11601199.
DOI: 10.1126/sciadv.ado5982.
Lyu A, Nam S, Humphrey R, Horton T, Ehrlich L
Exp Mol Med. 2024; 56(11):2337-2347.
PMID: 39482533
PMC: 11612169.
DOI: 10.1038/s12276-024-01335-7.
Endothelial to mesenchymal Notch signaling regulates skeletal repair.
Novak S, Tanigawa H, Singh V, Root S, Schmidt T, Hankenson K
JCI Insight. 2024; 9(12).
PMID: 38781018
PMC: 11383173.
DOI: 10.1172/jci.insight.181073.
Prevalence and clinical impact of CD56 and T-cell marker expression in acute myeloid leukaemia: A single-centre retrospective analysis.
Shaforostova I, Call S, Evers G, Reicherts C, Angenendt L, Stelljes M
EJHaem. 2024; 5(1):93-104.
PMID: 38406551
PMC: 10887264.
DOI: 10.1002/jha2.827.
The ESCRT protein CHMP5 promotes T cell leukemia by controlling BRD4-p300-dependent transcription.
Umphred-Wilson K, Ratnayake S, Tang Q, Wang R, Devaiah B, Zhou L
bioRxiv. 2024; .
PMID: 38352301
PMC: 10862731.
DOI: 10.1101/2024.01.29.577409.
Engineered T cells from induced pluripotent stem cells: from research towards clinical implementation.
Netsrithong R, Garcia-Perez L, Themeli M
Front Immunol. 2024; 14:1325209.
PMID: 38283344
PMC: 10811463.
DOI: 10.3389/fimmu.2023.1325209.
Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia.
Hussan S, Ali M, Fatima M, Altaf M, Sadaf S
Ann Hematol. 2023; 103(2):511-523.
PMID: 37922005
DOI: 10.1007/s00277-023-05515-9.
Uncovering NOTCH1 as a Promising Target in the Treatment of -Rearranged Leukemia.
Fischer J, Erkner E, Fitzel R, Radszuweit P, Keppeler H, Korkmaz F
Int J Mol Sci. 2023; 24(19).
PMID: 37833915
PMC: 10572120.
DOI: 10.3390/ijms241914466.
c-Myc inhibits LAPTM5 expression in B-cell lymphomas.
Zhang Y, Zhang X, Zhang Y, Xu H, Wei Z, Wang X
Ann Hematol. 2023; 102(12):3499-3513.
PMID: 37713124
DOI: 10.1007/s00277-023-05434-9.
DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia.
Sexauer A, Alexe G, Gustafsson K, Zanetakos E, Milosevic J, Ayres M
Blood Adv. 2023; 7(21):6685-6701.
PMID: 37648673
PMC: 10641474.
DOI: 10.1182/bloodadvances.2023010337.
NOTCH Signaling in Mantle Cell Lymphoma: Biological and Clinical Implications.
Deshotels L, Safa F, Saba N
Int J Mol Sci. 2023; 24(12).
PMID: 37373427
PMC: 10299455.
DOI: 10.3390/ijms241210280.
Integrated role of human thymic stromal cells in hematopoietic stem cell extravasation.
Watson S, Javanmardi Y, Zanieri L, Shahreza S, Ragazzini R, Bonfanti P
Bioeng Transl Med. 2023; 8(2):e10454.
PMID: 36925684
PMC: 10013751.
DOI: 10.1002/btm2.10454.
Notch Signaling in Acute Inflammation and Sepsis.
Gallenstein N, Tichy L, Weigand M, Schenz J
Int J Mol Sci. 2023; 24(4).
PMID: 36834869
PMC: 9967996.
DOI: 10.3390/ijms24043458.
Multi-modular structure of the gene regulatory network for specification and commitment of murine T cells.
Shin B, Rothenberg E
Front Immunol. 2023; 14:1108368.
PMID: 36817475
PMC: 9928580.
DOI: 10.3389/fimmu.2023.1108368.
Central Nervous System Progression/Relapse in Mature T- and NK-Cell Lymphomas.
Bhansali R, Barta S
Cancers (Basel). 2023; 15(3).
PMID: 36765882
PMC: 9913807.
DOI: 10.3390/cancers15030925.
Role of Notch2 pathway in mature B cell malignancies.
Mesini N, Fiorcari S, Atene C, Maffei R, Potenza L, Luppi M
Front Oncol. 2023; 12:1073672.
PMID: 36686759
PMC: 9846264.
DOI: 10.3389/fonc.2022.1073672.
Notch Partners in the Long Journey of T-ALL Pathogenesis.
Toribio M, Gonzalez-Garcia S
Int J Mol Sci. 2023; 24(2).
PMID: 36674902
PMC: 9866461.
DOI: 10.3390/ijms24021383.